Evidence map›Paper›PMID 28253855›Full record

ArticleBMC bioinformatics2017

SeqCNV: a novel method for identification of copy number variations in targeted next-generation sequencing data.

Yong Chen, Li Zhao, Yi Wang, Ming Cao, Violet Gelowani, Mingchu Xu, Smriti A Agrawal, Yumei Li, Stephen P Daiger, Richard Gibbs and 2 more

Abstract read
In one paragraph

Article in BMC bioinformatics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yong ChenShanghai Key Lab of Intelligent Information Processing, Shanghai, China.
Li ZhaoStructural and Computational Biology & Molecular Biophysics Graduate Program, Baylor College of Medicine, Houston, TX, USA.
Yi WangSchool of Life Sciences, Fudan University, Shanghai, China.
Ming CaoUniversity of Texas Health Science Center, Houston, TX, USA.
Violet GelowaniHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.
Mingchu XuHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.
Smriti A AgrawalHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.
Yumei LiHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.
Stephen P DaigerDepartment of Ophthalmology and Visual Sciences, University of Texas Health Science Center, Houston, TX, USA.
Richard GibbsHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.
Fei WangShanghai Key Lab of Intelligent Information Processing, Shanghai, China. wangfei@fudan.edu.cn.ORCID http://orcid.org/0000-0001-5890-0448
Rui ChenStructural and Computational Biology & Molecular Biophysics Graduate Program, Baylor College of Medicine, Houston, TX, USA. ruichen@bcm.edu.

Funding

GENETICS OF EARLY ONSET RETINAL DISEASESR01EY018571 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI RUI CHEN · 2008 to 2026
$7.2M
Molecular Basis of Human Visual System DisordersR01EY022356 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI RUI CHEN · 2012 to 2026
$6.1M
DNA LINKAGE STUDIES OF DEGENERATIVE RETINAL DISEASESR01EY007142 · NEI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI DAIGER, STEPHEN P · 1989 to 2017
$4.1M
Molecular Mechanisms of Human Retinal DiseaseR01EY020540 · NEI · BAYLOR COLLEGE OF MEDICINE · PI CHEN, RUI, MARDON, GRAEME · 2011 to 2017
$2.3M
NEI NIH HHS R01 EY007142NEI NIH HHS R01 EY018571NEI NIH HHS R01 EY020540NEI NIH HHS R01 EY022356
6 · The paper itself

Abstract

backgroundTargeted next-generation sequencing (NGS) has been widely used as a cost-effective way to identify the genetic basis of human disorders. Copy number variations (CNVs) contribute significantly to human genomic variability, some of which can lead to disease. However, effective detection of CNVs from targeted capture sequencing data remains challenging.

resultsHere we present SeqCNV, a novel CNV calling method designed to use capture NGS data. SeqCNV extracts the read depth information and utilizes the maximum penalized likelihood estimation (MPLE) model to identify the copy number ratio and CNV boundary. We applied SeqCNV to both bacterial artificial clone (BAC) and human patient NGS data to identify CNVs. These CNVs were validated by array comparative genomic hybridization (aCGH).

conclusionsSeqCNV is able to robustly identify CNVs of different size using capture NGS data. Compared with other CNV-calling methods, SeqCNV shows a significant improvement in both sensitivity and specificity.

Indexed as

DNA Copy Number VariationsGenome, HumanSoftwareHigh-Throughput Nucleotide SequencingHumansLikelihood FunctionsSensitivity and SpecificitySequence Analysis, DNACopy number variationMaximum penalized likelihood estimationNext-generation sequencing

Identifiers

PMID28253855
PMCPMC5335817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.